SlideShare une entreprise Scribd logo
1  sur  40
Secondary HaemostasisSecondary Haemostasis
Dr.Ibrahim Khider Ibrahim
Al-Neelain University -FMLS
Haematology Department
4th
year March 2018
4th Year LEctures-FMLs-Neelain
Overview
 Vasoconstriction and PLT
plug formation are early,
important steps in
haemostasis.
 Further maintenance of
haemostasis, however,
requires the formation of
fibrin clots via blood
coagulation.
4th Year LEctures-FMLs-Neelain
Overview
 The clots, insoluble
networks of fibrin, serve to
solidify the PLT plug.
 Blood coagulation is the end
result of complex
sequential reactions
involving trace plasma
proteins called coagulation
factors. 4th Year LEctures-FMLs-Neelain
4th Year LEctures-FMLs-Neelain
Haemostatic Plug Formation
Thrombin
AGGREGATION
Fibrin
Hemostatic
clot
ClottingPlatelet Aggregation
0 min 10 min5 min
SECONDARY
PRIMARY
COAGULATION
Factor Nomenclature
 Each factor was assigned a Roman numerical letter
by
 International Committee in Nomenclature of Blood
Coagulation Factors
 in the order of its discovery, not its place in the reaction
sequence.
 They are percent as inactive forms and numerated
as I-XIII.
4th Year LEctures-FMLs-Neelain
4th Year LEctures-FMLs-Neelain
4th Year LEctures-FMLs-Neelain
Factor Nomenclature
 In case of the active forms (a) is added as a
suffix to the numerical roman letter
 (VIII VIIIa. )
 Zymogene
 They are usually inactive precursors of an
enzyme Inactive factors
 (Except:V,VIIIand XIII).
 Serine protease
 They are enzymes that cleave peptide
bonds in proteins, in which serine serves as
the  active site.
4th Year LEctures-FMLs-Neelain
4th Year LEctures-FMLs-Neelain
4th Year LEctures-FMLs-Neelain
Classification of Coagulation
Factors
 Based on functional or structural properties
 Physical groupings
 Prothrombin
 Fibrinogen
 Contact
 Functional Groupings
 Substrate
 Cofactors
 Enzyme
4th Year LEctures-FMLs-Neelain
Physical Groupings
4th Year LEctures-FMLs-Neelain
Prothrombin Group
 II, VII, IX, X
 Protein C, Protein S, Protein Z
 Vitamin K dependent
 Synthesized in liver
 Small mw (50,000-100,000)
 Contain a domain that is critical for calcium
binding
 Heat stable
 Inhibited by warfarin
4th Year LEctures-FMLs-Neelain
Fibrinogen group
 I, V, VIII, XIII
 Thrombin acts on all these factors
 Synthesized in liver
 Exception: VIII:vWF which is produced by endothelial
cells and megakaryocytes
 Large mw (250,000)
 ALL are consumed in the clotting process, since
they are NOT enzymes
4th Year LEctures-FMLs-Neelain
Contact Group
 XI, XII, HMWK(HK), PK
 Produced in liver
 Activated upon contact with a negatively charged
surface
 Collagen in vivo
 Glass, Kaolin in vitro
 Large mw (80,000-173,000)
 Purpose: activate the intrinsic pathway & fibrinolytic
system 4th Year LEctures-FMLs-Neelain
Functional Groupings
 Substrates: substance upon which enzymes act
 Factor I:fibrinogen
 Cofactors: speed up the activities of enzymes
 (i.e) Factor V: Proaccelerin
 Enzymes
 Transglutaminase
 Factor XIIIa only
 Serine protease
 Inactive until converted to enzymes
 Once activated, assist in reaction, but are not
consumed or used up
4th Year LEctures-FMLs-Neelain
What’s so Special About Vitamin K?
 Where does it come from?
 Green leafy vegetables, fish and liver
 Gram-negative intestinal bacteria
 What does it do?
 Vitamin K is necessary for the carboxylation
of glutamic acid. Carboxylation is essential
for binding coagulation factors to negatively-
charged phospholipid surfaces via Ca++
bridges.
Carboxylation reactions also reduce vitamin K
to be recycled.
4th Year LEctures-FMLs-Neelain
What’s so Special About Vitamin K?
 Why do we care?
 Vitamin K antagonist drugs such as
warfin/coumadin inhibit the activity of
the recycling of Vitamin K, so the
reduced form can not be made
 Deficiencies of Vitamin K result in the
production of non-functional factors
which can not participate in coagulation
reactions
4th Year LEctures-FMLs-Neelain
Intrinsic Pathway
 The intrinsic pathway triggered
when the blood comes in contact
with any negatively charged non-
endothelial surface.
4th Year LEctures-FMLs-Neelain
Intrinsic Pathways
 Following endothelial injury:
 the contact factors are adsorbed to
the sub endothelium
 activated by the negatively charged
connective tissue fibers such as
collagen fibers.
4th Year LEctures-FMLs-Neelain
Extrinsic Pathway
 The extrinsic pathway is triggered
by tissue factor (F III) which is
released from damaged tissues.
4th Year LEctures-FMLs-Neelain
Common pathway
 Both intrinsic and extrinsic
pathways are lead to common
pathway.
4th Year LEctures-FMLs-Neelain
4th Year LEctures-FMLs-Neelain
4th Year LEctures-FMLs-Neelain
4th Year LEctures-FMLs-Neelain
4th Year LEctures-FMLs-Neelain
Regulation of coagulation
 In the absence of strict regulatory
mechanism, the coagulation mechanism once
activated would continue until all the
fibrinogen in the plasma converted to fibrin.
 Human blood contains many agents that
inhibit the activity of activated clotting
factors.
4th Year LEctures-FMLs-Neelain
Naturally occurring Inhibitors
4th Year LEctures-FMLs-Neelain
Antithrombin III (AT III)
 AT III is a major inhibitor of thrombin.
 It is formed by the liver
 Complexes to heparin sulfate and
inactivates the serine proteases :
 Thrombin, FXIa, FXa,FIXa, FVIIa.
4th Year LEctures-FMLs-Neelain
Antithrombin IIIAntithrombin III
Heparin
ThrombinThrombin
Antithrombin IIIAntithrombin III
Antithrombin IIIAntithrombin III
ThrombinThrombin
Proposed Mechanism of AT III-Heparin
System
HeparinThrombin Antithrombin
III
Lysine
sites
Serine site
Arginine
site
H
Th
H
AT III
AT III
Th
4th Year LEctures-FMLs-Neelain
. Heparin cofactor II (HCII)
 It is a plasma protein that selectively inhibit
thrombin.
 Like AT III, the activity of HCII is
stimulated markedly in the presence of
heparin.
4th Year LEctures-FMLs-Neelain
α2-macroglobulin
 It is a large plasma protein,
 Inhibit thrombin but less effective
than ATIII
 Heparin does not enhance its
activity.
 Also inhibits Xa and kallikrein
4th Year LEctures-FMLs-Neelain
Protein C/S system
 Protein C and protein S are vitamin-k
dependent proteins, synthesized by the
liver.
 Rapid activation of protein C occurs on
the surface of endothelial cells where
 The thrombin-thrombomodulin complex is
formed.
4th Year LEctures-FMLs-Neelain
Protein C/S system
 Once activated APC forms a complex
with protein S on the surface of either
PLTs or endothelium
 This complex selectively degrades
factor Va and factor VIIIa.
4th Year LEctures-FMLs-Neelain
4th Year LEctures-FMLs-Neelain
 Tissue factor pathway inhibitor(TFPI)
 Act on extrinsic pathway factors, mainly
FVIIa.
 Also it inhibits Xa.
4th Year LEctures-FMLs-Neelain
Proposed Mechanism of Tissue Factor
Pathway Inhibitor (TFPI) Activity
F-Xa
Endothelium
Tissue factorF-VIIa
TFPI
F-Xa
TFPI
TFPI
F-Xa
4th Year LEctures-FMLs-Neelain
Protein Z-dependent inhibitor
 Protein Z (PZ) is a 62-kDa vitamin K-
dependent plasma protein
 Serves as a cofactor for PZ-dependent
inhibitor (ZPI).
 Inhibition of FXa
 Also has an inhibitory effect on Xia.
4th Year LEctures-FMLs-Neelain
4th Year LEctures-FMLs-Neelain

Contenu connexe

Tendances

Coagulation Disorders
Coagulation DisordersCoagulation Disorders
Coagulation Disorders
Ghie Santos
 
PT APTT Technical Information
PT APTT Technical InformationPT APTT Technical Information
PT APTT Technical Information
Priyank Dubey
 
Reticulocyte count
Reticulocyte countReticulocyte count
Reticulocyte count
Prbn Shah
 

Tendances (20)

Coagulation Disorders
Coagulation DisordersCoagulation Disorders
Coagulation Disorders
 
Fibrinolysis
Fibrinolysis Fibrinolysis
Fibrinolysis
 
Haemostasis
HaemostasisHaemostasis
Haemostasis
 
PT APTT Technical Information
PT APTT Technical InformationPT APTT Technical Information
PT APTT Technical Information
 
Leukocyte disorders
Leukocyte disordersLeukocyte disorders
Leukocyte disorders
 
Diagnosis of hemolytic anemia
Diagnosis of hemolytic anemiaDiagnosis of hemolytic anemia
Diagnosis of hemolytic anemia
 
Chapter 3 proteins
Chapter 3 proteinsChapter 3 proteins
Chapter 3 proteins
 
Platelet disorders
Platelet disordersPlatelet disorders
Platelet disorders
 
Fibrinolysis system
Fibrinolysis systemFibrinolysis system
Fibrinolysis system
 
Prothrombin time
Prothrombin timeProthrombin time
Prothrombin time
 
Bleeding and Thrombotic Disorders
Bleeding and Thrombotic Disorders Bleeding and Thrombotic Disorders
Bleeding and Thrombotic Disorders
 
Bleeding disorders Causes, Types, and Diagnosis
Bleeding disorders Causes, Types, and DiagnosisBleeding disorders Causes, Types, and Diagnosis
Bleeding disorders Causes, Types, and Diagnosis
 
Coagulation disorders
Coagulation disordersCoagulation disorders
Coagulation disorders
 
Reticulocyte count
Reticulocyte countReticulocyte count
Reticulocyte count
 
Platelets disorders
Platelets disordersPlatelets disorders
Platelets disorders
 
Normal hemostasis and coagulation
Normal hemostasis and coagulationNormal hemostasis and coagulation
Normal hemostasis and coagulation
 
RED BLOOD CELLS.pptx
RED BLOOD CELLS.pptxRED BLOOD CELLS.pptx
RED BLOOD CELLS.pptx
 
Anemia, types and causes
Anemia, types and causesAnemia, types and causes
Anemia, types and causes
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Normal haemostasis
Normal haemostasisNormal haemostasis
Normal haemostasis
 

Similaire à Secondary haemostasis-Fourth Year March 2018

clottingfactors-160317182528-converted.pptx
clottingfactors-160317182528-converted.pptxclottingfactors-160317182528-converted.pptx
clottingfactors-160317182528-converted.pptx
Sakshi617058
 

Similaire à Secondary haemostasis-Fourth Year March 2018 (20)

Coagulation Cascade
Coagulation CascadeCoagulation Cascade
Coagulation Cascade
 
Cell based model of coagulation
Cell based model of coagulationCell based model of coagulation
Cell based model of coagulation
 
Coagulation, in diagnostic hematology PPTX
Coagulation, in diagnostic hematology PPTXCoagulation, in diagnostic hematology PPTX
Coagulation, in diagnostic hematology PPTX
 
NORMAL HEMOSTASIS
NORMAL HEMOSTASISNORMAL HEMOSTASIS
NORMAL HEMOSTASIS
 
Coagulation of Blood
Coagulation of BloodCoagulation of Blood
Coagulation of Blood
 
Clotting factors
Clotting factorsClotting factors
Clotting factors
 
Thrombocytes and Hemostasis
Thrombocytes and HemostasisThrombocytes and Hemostasis
Thrombocytes and Hemostasis
 
clottingfactors-160317182528-converted.pptx
clottingfactors-160317182528-converted.pptxclottingfactors-160317182528-converted.pptx
clottingfactors-160317182528-converted.pptx
 
Overview haemostasis 2
Overview haemostasis 2Overview haemostasis 2
Overview haemostasis 2
 
HAEMOSTASIS LEVEL 6.pptx
HAEMOSTASIS LEVEL 6.pptxHAEMOSTASIS LEVEL 6.pptx
HAEMOSTASIS LEVEL 6.pptx
 
bleedig & clotting disorders
 bleedig & clotting disorders bleedig & clotting disorders
bleedig & clotting disorders
 
CME: Bleeding Disorders - Applied Physiology
CME: Bleeding Disorders - Applied PhysiologyCME: Bleeding Disorders - Applied Physiology
CME: Bleeding Disorders - Applied Physiology
 
phsiology of blood coagulation by dr chandbaby ansari.pdf
phsiology of blood coagulation by dr chandbaby ansari.pdfphsiology of blood coagulation by dr chandbaby ansari.pdf
phsiology of blood coagulation by dr chandbaby ansari.pdf
 
Secondary hemostasis - coagulation cascades and lab tests
Secondary hemostasis - coagulation cascades and lab testsSecondary hemostasis - coagulation cascades and lab tests
Secondary hemostasis - coagulation cascades and lab tests
 
Physiology of haemostasis
Physiology of haemostasisPhysiology of haemostasis
Physiology of haemostasis
 
Hemostasis Surgury 2
Hemostasis Surgury 2Hemostasis Surgury 2
Hemostasis Surgury 2
 
Homeostasis.pptx
Homeostasis.pptxHomeostasis.pptx
Homeostasis.pptx
 
HEMOSTASIS & COAGULATION.pptx
HEMOSTASIS & COAGULATION.pptxHEMOSTASIS & COAGULATION.pptx
HEMOSTASIS & COAGULATION.pptx
 
Hemostasis and blood coagulation general pathology
Hemostasis and blood  coagulation general pathologyHemostasis and blood  coagulation general pathology
Hemostasis and blood coagulation general pathology
 
PC of Blood and Blood forming agents.pdf
PC of Blood and Blood forming agents.pdfPC of Blood and Blood forming agents.pdf
PC of Blood and Blood forming agents.pdf
 

Plus de Ibrahim khidir ibrahim osman

Plus de Ibrahim khidir ibrahim osman (20)

Introduction to Haemostasis
Introduction to Haemostasis Introduction to Haemostasis
Introduction to Haemostasis
 
Megaloblasticanemia
MegaloblasticanemiaMegaloblasticanemia
Megaloblasticanemia
 
Lupus anticoagulants
Lupus anticoagulantsLupus anticoagulants
Lupus anticoagulants
 
Blood transfusion guidelines in clinical practice
Blood transfusion guidelines in clinical practiceBlood transfusion guidelines in clinical practice
Blood transfusion guidelines in clinical practice
 
Anticoagulant therapy
Anticoagulant therapyAnticoagulant therapy
Anticoagulant therapy
 
Kell blood group system
Kell blood group systemKell blood group system
Kell blood group system
 
Sickle cell
Sickle cell Sickle cell
Sickle cell
 
RBC Membrane Defects
RBC Membrane DefectsRBC Membrane Defects
RBC Membrane Defects
 
Apherisis
ApherisisApherisis
Apherisis
 
Haem systmic
Haem systmicHaem systmic
Haem systmic
 
Real time pcr
Real time pcrReal time pcr
Real time pcr
 
11 haematology and pregnancy outreach
11 haematology and pregnancy outreach11 haematology and pregnancy outreach
11 haematology and pregnancy outreach
 
Rhesus
RhesusRhesus
Rhesus
 
Basics of immunohematology - copy
Basics of immunohematology - copyBasics of immunohematology - copy
Basics of immunohematology - copy
 
G6PD Deficiency Anaemai
G6PD Deficiency AnaemaiG6PD Deficiency Anaemai
G6PD Deficiency Anaemai
 
Sicklecell
SicklecellSicklecell
Sicklecell
 
Haemolytic anaemias
Haemolytic anaemiasHaemolytic anaemias
Haemolytic anaemias
 
Association of Angiotensin-converting Enzyme Gene Insertion/ Deletion Polymor...
Association of Angiotensin-converting Enzyme Gene Insertion/ Deletion Polymor...Association of Angiotensin-converting Enzyme Gene Insertion/ Deletion Polymor...
Association of Angiotensin-converting Enzyme Gene Insertion/ Deletion Polymor...
 
Introduction to Anaemia
Introduction to AnaemiaIntroduction to Anaemia
Introduction to Anaemia
 
Iron overload
Iron overload Iron overload
Iron overload
 

Dernier

Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 

Dernier (20)

Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Philosophy of china and it's charactistics
Philosophy of china and it's charactisticsPhilosophy of china and it's charactistics
Philosophy of china and it's charactistics
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Tatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsTatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf arts
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 

Secondary haemostasis-Fourth Year March 2018

  • 1. Secondary HaemostasisSecondary Haemostasis Dr.Ibrahim Khider Ibrahim Al-Neelain University -FMLS Haematology Department 4th year March 2018 4th Year LEctures-FMLs-Neelain
  • 2. Overview  Vasoconstriction and PLT plug formation are early, important steps in haemostasis.  Further maintenance of haemostasis, however, requires the formation of fibrin clots via blood coagulation. 4th Year LEctures-FMLs-Neelain
  • 3. Overview  The clots, insoluble networks of fibrin, serve to solidify the PLT plug.  Blood coagulation is the end result of complex sequential reactions involving trace plasma proteins called coagulation factors. 4th Year LEctures-FMLs-Neelain
  • 4. 4th Year LEctures-FMLs-Neelain Haemostatic Plug Formation Thrombin AGGREGATION Fibrin Hemostatic clot ClottingPlatelet Aggregation 0 min 10 min5 min SECONDARY PRIMARY COAGULATION
  • 5. Factor Nomenclature  Each factor was assigned a Roman numerical letter by  International Committee in Nomenclature of Blood Coagulation Factors  in the order of its discovery, not its place in the reaction sequence.  They are percent as inactive forms and numerated as I-XIII. 4th Year LEctures-FMLs-Neelain
  • 8. Factor Nomenclature  In case of the active forms (a) is added as a suffix to the numerical roman letter  (VIII VIIIa. )  Zymogene  They are usually inactive precursors of an enzyme Inactive factors  (Except:V,VIIIand XIII).  Serine protease  They are enzymes that cleave peptide bonds in proteins, in which serine serves as the  active site. 4th Year LEctures-FMLs-Neelain
  • 11. Classification of Coagulation Factors  Based on functional or structural properties  Physical groupings  Prothrombin  Fibrinogen  Contact  Functional Groupings  Substrate  Cofactors  Enzyme 4th Year LEctures-FMLs-Neelain
  • 12. Physical Groupings 4th Year LEctures-FMLs-Neelain
  • 13. Prothrombin Group  II, VII, IX, X  Protein C, Protein S, Protein Z  Vitamin K dependent  Synthesized in liver  Small mw (50,000-100,000)  Contain a domain that is critical for calcium binding  Heat stable  Inhibited by warfarin 4th Year LEctures-FMLs-Neelain
  • 14. Fibrinogen group  I, V, VIII, XIII  Thrombin acts on all these factors  Synthesized in liver  Exception: VIII:vWF which is produced by endothelial cells and megakaryocytes  Large mw (250,000)  ALL are consumed in the clotting process, since they are NOT enzymes 4th Year LEctures-FMLs-Neelain
  • 15. Contact Group  XI, XII, HMWK(HK), PK  Produced in liver  Activated upon contact with a negatively charged surface  Collagen in vivo  Glass, Kaolin in vitro  Large mw (80,000-173,000)  Purpose: activate the intrinsic pathway & fibrinolytic system 4th Year LEctures-FMLs-Neelain
  • 16. Functional Groupings  Substrates: substance upon which enzymes act  Factor I:fibrinogen  Cofactors: speed up the activities of enzymes  (i.e) Factor V: Proaccelerin  Enzymes  Transglutaminase  Factor XIIIa only  Serine protease  Inactive until converted to enzymes  Once activated, assist in reaction, but are not consumed or used up 4th Year LEctures-FMLs-Neelain
  • 17. What’s so Special About Vitamin K?  Where does it come from?  Green leafy vegetables, fish and liver  Gram-negative intestinal bacteria  What does it do?  Vitamin K is necessary for the carboxylation of glutamic acid. Carboxylation is essential for binding coagulation factors to negatively- charged phospholipid surfaces via Ca++ bridges. Carboxylation reactions also reduce vitamin K to be recycled. 4th Year LEctures-FMLs-Neelain
  • 18. What’s so Special About Vitamin K?  Why do we care?  Vitamin K antagonist drugs such as warfin/coumadin inhibit the activity of the recycling of Vitamin K, so the reduced form can not be made  Deficiencies of Vitamin K result in the production of non-functional factors which can not participate in coagulation reactions 4th Year LEctures-FMLs-Neelain
  • 19. Intrinsic Pathway  The intrinsic pathway triggered when the blood comes in contact with any negatively charged non- endothelial surface. 4th Year LEctures-FMLs-Neelain
  • 20. Intrinsic Pathways  Following endothelial injury:  the contact factors are adsorbed to the sub endothelium  activated by the negatively charged connective tissue fibers such as collagen fibers. 4th Year LEctures-FMLs-Neelain
  • 21. Extrinsic Pathway  The extrinsic pathway is triggered by tissue factor (F III) which is released from damaged tissues. 4th Year LEctures-FMLs-Neelain
  • 22. Common pathway  Both intrinsic and extrinsic pathways are lead to common pathway. 4th Year LEctures-FMLs-Neelain
  • 27. Regulation of coagulation  In the absence of strict regulatory mechanism, the coagulation mechanism once activated would continue until all the fibrinogen in the plasma converted to fibrin.  Human blood contains many agents that inhibit the activity of activated clotting factors. 4th Year LEctures-FMLs-Neelain
  • 28. Naturally occurring Inhibitors 4th Year LEctures-FMLs-Neelain
  • 29. Antithrombin III (AT III)  AT III is a major inhibitor of thrombin.  It is formed by the liver  Complexes to heparin sulfate and inactivates the serine proteases :  Thrombin, FXIa, FXa,FIXa, FVIIa. 4th Year LEctures-FMLs-Neelain
  • 30. Antithrombin IIIAntithrombin III Heparin ThrombinThrombin Antithrombin IIIAntithrombin III Antithrombin IIIAntithrombin III ThrombinThrombin
  • 31. Proposed Mechanism of AT III-Heparin System HeparinThrombin Antithrombin III Lysine sites Serine site Arginine site H Th H AT III AT III Th 4th Year LEctures-FMLs-Neelain
  • 32. . Heparin cofactor II (HCII)  It is a plasma protein that selectively inhibit thrombin.  Like AT III, the activity of HCII is stimulated markedly in the presence of heparin. 4th Year LEctures-FMLs-Neelain
  • 33. α2-macroglobulin  It is a large plasma protein,  Inhibit thrombin but less effective than ATIII  Heparin does not enhance its activity.  Also inhibits Xa and kallikrein 4th Year LEctures-FMLs-Neelain
  • 34. Protein C/S system  Protein C and protein S are vitamin-k dependent proteins, synthesized by the liver.  Rapid activation of protein C occurs on the surface of endothelial cells where  The thrombin-thrombomodulin complex is formed. 4th Year LEctures-FMLs-Neelain
  • 35. Protein C/S system  Once activated APC forms a complex with protein S on the surface of either PLTs or endothelium  This complex selectively degrades factor Va and factor VIIIa. 4th Year LEctures-FMLs-Neelain
  • 37.  Tissue factor pathway inhibitor(TFPI)  Act on extrinsic pathway factors, mainly FVIIa.  Also it inhibits Xa. 4th Year LEctures-FMLs-Neelain
  • 38. Proposed Mechanism of Tissue Factor Pathway Inhibitor (TFPI) Activity F-Xa Endothelium Tissue factorF-VIIa TFPI F-Xa TFPI TFPI F-Xa 4th Year LEctures-FMLs-Neelain
  • 39. Protein Z-dependent inhibitor  Protein Z (PZ) is a 62-kDa vitamin K- dependent plasma protein  Serves as a cofactor for PZ-dependent inhibitor (ZPI).  Inhibition of FXa  Also has an inhibitory effect on Xia. 4th Year LEctures-FMLs-Neelain